The Pathway Linking High Glucose to Inflammation That Can Cause Diabetes Complications
Diabetes greatly raises the risk for heart, blood vessel and kidney disease, and scientists have been searching for explanations of why high blood sugar would contribute to these severe complications. Now a team of researchers at the University of Virginia Health System is offering a new explanation for this phenomenon.
The team, led by Jerry Nadler, M.D., has completed the first study that shows high glucose can increase levels of key proteins that result in inflammation. The inflammation process in blood vessels and the kidney can lead to a build-up of cells (atherosclerosis) and damage to tissues that can constrict the passage of blood through vessels. This blockage can lead to heart attacks and affect the kidney, leading to end-stage renal (kidney) disease.
The researchers discovered that high glucose treatment significantly increased levels of several types of pro-inflammatory cytokines like interleukin 12 (IL-12) produced by macrophages, an immune system cell that plays a central role in chronic inflammation in diabetes, atherosclerosis and other immune disorders. Cytokines, substances that are secreted by immune cells, can program certain white blood cells to become T helper cells (Th1). The cytokine IL-12 and Th1 cell infiltration has emerged as an important pathway for the development of autoimmune diabetes as well as chronic inflammation linked with atherosclerosis. Previous studies have found that reducing levels of the cytokine IL-12 is associated with reduced atherosclerosis in mouse models.